Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Peginterferon beta
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Peginterferon beta-1a 125micrograms/0.5ml inj pf dispos dev
0802040APAAABAB
|
Peginterferon B | Peginterferon beta | Malignant Disease and Immunosuppression | No data available |
|
Peginterferon beta-1a 63microg and 94microg/0.5ml inj
0802040APAAAAAA
|
Peginterferon B | Peginterferon beta | Malignant Disease and Immunosuppression | No data available |
|
Plegridy 125micrograms/0.5ml inj pre-filled pens
0802040APBBABAB
|
Plegridy | Peginterferon beta | Malignant Disease and Immunosuppression | No data available |
|
Plegridy 63mcg/0.5ml and 94mcg/0.5ml inj pf pens TIP
0802040APBBAAAA
|
Plegridy | Peginterferon beta | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.